Loading...
XHKG
0546
Market cap1.39bUSD
Oct 09, Last price  
4.33HKD
1D
-0.69%
1Q
-9.41%
Jan 2017
13.65%
IPO
52.46%
Name

Fufeng Group Ltd

Chart & performance

D1W1MN
XHKG:0546 chart
P/E
3.75
P/S
0.33
EPS
0.98
Div yield, %
13.42%
Shrs. gr., 5y
-0.21%
Rev. gr., 5y
10.81%
Revenues
27.88b
+0.44%
1,787,247,0002,445,652,0003,585,343,0004,632,884,0006,416,425,0008,399,246,00011,111,920,00011,366,722,00011,297,696,00011,225,722,00011,803,131,00013,033,501,00013,764,645,00016,170,850,00016,690,736,00021,539,841,00027,474,639,00028,006,875,00027,757,310,00027,879,194,000
Net income
2.47b
+6.61%
240,483,00045,069,000294,706,000928,285,000966,051,000604,137,000426,553,000506,132,000626,428,000516,261,0001,092,512,0001,382,380,0001,845,039,0001,137,223,000629,901,0001,280,640,0003,861,078,0003,144,124,0002,312,384,0002,465,228,000
CFO
2.91b
-1.49%
183,981,000-38,078,000448,943,000586,174,0001,119,950,000248,248,000760,435,0001,038,529,0001,641,726,0001,148,638,0002,089,941,0001,202,209,0001,509,618,000892,160,000205,618,0002,774,430,0003,600,102,0001,704,877,0002,955,298,0002,911,344,000
Dividend
Sep 09, 20260.064 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Fufeng Group Limited, an investment holding company, specializes in the global production and distribution of fermentation-based food additives, biochemicals, and starch-derived products, operating across markets in the People's Republic of China and internationally. Its business is structured into several key segments: Food Additives, Animal Nutrition, High-End Amino Acid, Colloid, and an encompassing 'Other' segment. The Food Additives division is responsible for manufacturing and selling items such as monosodium glutamate (MSG), starch sweeteners, glutamic acid, compound seasonings, and corn oil. The Animal Nutrition segment focuses on producing and selling refined corn products, threonine, and lysine. High-end amino acids are offered through its dedicated segment, while the Colloid segment provides specialty gums like xanthan and gellan gum. The 'Other' segment encompasses a diverse range of products, including fertilizers, synthetic ammonia, and pharmaceuticals. Beyond these core activities, Fufeng Group is also engaged in the manufacturing and sale of construction materials such as autoclaved aerated concrete blocks and bricks, alongside eubacteria material medicine and various preparations. The company actively invests in the research, development, promotion, and industrialization of innovative biological techniques and their resultant achievements. Furthermore, it deals in cosmetics, biological products, and health foods, while also offering logistics, equity investment, and biological technique information services. Fufeng Group Limited was founded in 1999 and is headquartered in Linyi, People's Republic of China.

Key people

Guangyu Li
Co-Chief Executive Officer, Executive Director · since 2024
Wing Yiu Yau
Chief Financial Officer, Company Secretary · since 2023
Jingbin Huang
General Manager · since 2021
Xuechun Li
Executive Chairman of the Board · since 2016
Deheng Li
Co-Chief Executive Officer, Executive Director · since 2024
Non-Executive Independent Director · since 2019
Ming Li
Non-Executive Independent Director · since 2022
Youming Zhang
Non-Executive Independent Director · since 2021
IPO date
Feb 08, 2007
Employees
16,500
Domiciled in
CN
Incorporated in
KY
Headquarters & legal address
PO Box 2681
Cricket Square
Hutchins Drive
George Town KY1-1111
KY

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT